CryoLife Inc at Morgan Stanley Healthcare Conference Transcript
(technical difficulty)
So I mean this business has been focused on acceleration in the back half of the year and into 2020 and delivering this kind of high single-digit to double-digit earnings growth rate and JOTEC has been a big part of its story.
Questions & Answers
You're upgrading over half the portfolio, and I think we're in the process of a few regulatory filings.
Can you just start by giving us an update on where you are in that process?
Yes. So there's 3 new stent grafts that we're bringing out. They have been submitted for a regulatory approval. So there's a new thoracic stent graft called E-nya. A new off-the-shelf branched thoracoabdominal device called E-nside. Those are both submitted for CE mark in February and then we've got our third device, which is -- what's called the -- in a Frozen Elephant Trunk category, which is called E-vita Open Neo. That was submitted in early
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
